what is considered a microdose of glp 1 GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide microdose glp 1 oral Microdosing

Think of your gut like a garden

Unlike diabetic ketoacidosis, the diagnosis of euglycemic diabetic ketoacidosisis often overlooked because of the absence of hyperglycemia.

Women on GLP-1 drugs had an 8% lower risk of obesity-related cancers and a 20% lower risk of death from any cause, compared to those taking #DPP4 inhibitors

Schedule your free consultation today.

Both drugs belong to a family of modern therapies that have changed how clinicians treat diabetes and obesity

Only 8% of individuals (or one in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to do so at three years, according to the latest real-world research from Prime Therapeutics (Prime)